Global Health Clinics Ltd.

As of April 30, 2026, Global Health Clinics Ltd. has 9.39M shares outstanding.

These figures are as of April 30, 2026. The price-to-sales ratio is 32.33, and the price-to-book ratio stands at -0.08.

These figures are as of April 30, 2026. The EV/Sales ratio of 265.25 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

As of April 30, 2026, Global Health Clinics Ltd. maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -53.83, indicating conservative leverage, while an interest coverage ratio of -3.77 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended April 30, 2026. Return on assets (ROA) is negative at -4,419.94, reflecting losses generated across the asset base.

Over the twelve months ended April 30, 2026, Global Health Clinics Ltd. posted a gross margin of 67.99, reflecting its pricing power and cost economics. The operating margin of -8,220.20 and net profit margin of -10,385.67 provide insight into operational efficiency.

These figures cover the twelve months ended April 30, 2026. Free cash flow yield is negative at -135.84: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -142.25, meaning Global Health Clinics Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Global Health Clinics Ltd.'s most recent stock split took place on July 11, 2022 with a 20:1 split ratio.

As of April 30, 2026, Global Health Clinics Ltd. has an Altman Z-Score of -1,450.37, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.